Literature DB >> 17651449

Nosocomial spread of Pseudomonas aeruginosa producing the metallo-beta-lactamase VIM-2 in a Spanish hospital: clinical and epidemiological implications.

C Peña1, C Suarez, F Tubau, O Gutierrez, A Domínguez, A Oliver, M Pujol, F Gudiol, J Ariza.   

Abstract

Thirty-four isolates of pan-resistant Pseudomonas aeruginosa producing VIM-2 metallo-beta-lactamase (MBL) were detected at a university hospital in Spain (July 2004-September 2006). Eleven (32%) patients had clinically significant infections, and three (27%) of these patients died. A single clone of MBL-producing P. aeruginosa was identified by pulsed-field gel electrophoresis. A cluster of isolates associated with the vascular surgery ward involved ten patients and appeared as a series of low-grade, sustained and misdiagnosed endemic infections in the hospital. The identification of MBL-positive P. aeruginosa should be considered mandatory in the surveillance of pan-resistant P. aeruginosa and requires a high index of suspicion in the context of endemic infections with a low attack rate.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17651449     DOI: 10.1111/j.1469-0691.2007.01784.x

Source DB:  PubMed          Journal:  Clin Microbiol Infect        ISSN: 1198-743X            Impact factor:   8.067


  15 in total

1.  Biological markers of Pseudomonas aeruginosa epidemic high-risk clones.

Authors:  Xavier Mulet; Gabriel Cabot; Alain A Ocampo-Sosa; M Angeles Domínguez; Laura Zamorano; Carlos Juan; Fe Tubau; Cristina Rodríguez; Bartolomé Moyà; Carmen Peña; Luis Martínez-Martínez; Antonio Oliver
Journal:  Antimicrob Agents Chemother       Date:  2013-08-26       Impact factor: 5.191

2.  Chronic respiratory infections by mucoid carbapenemase-producing Pseudomonas aeruginosa strains, a new potential public health problem.

Authors:  Carlos Juan; Olivia Gutiérrez; Feliu Renom; Margarita Garau; Carmen Gallegos; Sebastián Albertí; José Luis Pérez; Antonio Oliver
Journal:  Antimicrob Agents Chemother       Date:  2008-04-07       Impact factor: 5.191

3.  Spread of multidrug-resistant Pseudomonas aeruginosa clones in a university hospital.

Authors:  Maria Koutsogiannou; Eleanna Drougka; Apostolos Liakopoulos; Eleni Jelastopulu; Efthimia Petinaki; Evangelos D Anastassiou; Iris Spiliopoulou; Myrto Christofidou
Journal:  J Clin Microbiol       Date:  2012-12-12       Impact factor: 5.948

4.  Large dissemination of VIM-2-metallo-{beta}-lactamase-producing pseudomonas aeruginosa strains causing health care-associated community-onset infections.

Authors:  Athanassios Tsakris; Aggeliki Poulou; Ioulia Kristo; Theodore Pittaras; Nicholas Spanakis; Spyros Pournaras; Fani Markou
Journal:  J Clin Microbiol       Date:  2009-09-23       Impact factor: 5.948

5.  Dispersal of carbapenemase blaVIM-1 gene associated with different Tn402 variants, mercury transposons, and conjugative plasmids in Enterobacteriaceae and Pseudomonas aeruginosa.

Authors:  Marta Tato; Teresa M Coque; Fernando Baquero; Rafael Cantón
Journal:  Antimicrob Agents Chemother       Date:  2009-11-09       Impact factor: 5.191

6.  Activity of a new antipseudomonal cephalosporin, CXA-101 (FR264205), against carbapenem-resistant and multidrug-resistant Pseudomonas aeruginosa clinical strains.

Authors:  Carlos Juan; Laura Zamorano; José L Pérez; Yigong Ge; Antonio Oliver
Journal:  Antimicrob Agents Chemother       Date:  2009-11-23       Impact factor: 5.191

7.  Genetic markers of widespread extensively drug-resistant Pseudomonas aeruginosa high-risk clones.

Authors:  Gabriel Cabot; Alain A Ocampo-Sosa; M Angeles Domínguez; Juan F Gago; Carlos Juan; Fe Tubau; Cristina Rodríguez; Bartolomé Moyà; Carmen Peña; Luis Martínez-Martínez; Antonio Oliver
Journal:  Antimicrob Agents Chemother       Date:  2012-10-08       Impact factor: 5.191

8.  Detailed epidemiological analysis as a strategy for evaluating the actual behavior of tuberculosis in an apparently low-incidence region.

Authors:  Ana Laura Guillén-Nepita; Gerardo Vázquez-Marrufo; Andrés Cruz-Hernández; Felipe García-Oliva; Reyna Cristina Zepeda-Gurrola; Ma Soledad Vázquez-Garcidueñas
Journal:  Pathog Glob Health       Date:  2020-09-14       Impact factor: 2.894

9.  Characterization of the new metallo-beta-lactamase VIM-13 and its integron-borne gene from a Pseudomonas aeruginosa clinical isolate in Spain.

Authors:  Carlos Juan; Alejandro Beceiro; Olivia Gutiérrez; Sebastián Albertí; Margalida Garau; José L Pérez; Germán Bou; Antonio Oliver
Journal:  Antimicrob Agents Chemother       Date:  2008-07-21       Impact factor: 5.191

10.  Molecular epidemiology and mechanisms of carbapenem resistance in Pseudomonas aeruginosa isolates from Spanish hospitals.

Authors:  O Gutiérrez; C Juan; E Cercenado; F Navarro; E Bouza; P Coll; J L Pérez; A Oliver
Journal:  Antimicrob Agents Chemother       Date:  2007-10-15       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.